Autophagy-enhancing drug candidate enters Phase 1 trial as longevity focused biotech eyes Alzheimer’s as a potential first indication.
Latest articles
Related articles
Popular articles
Featured
Newsletter
Subscribe to get the latest news, offers and special announcements.
